Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

Colorectal cancer (CRC) is the second most common cause of death from cancer in the US and the most prevalent malignant tumor ...

It was "Strike Out Cancer Night" at the Kenosha ballpark. KENOSHA, Wis. - Tuesday night, June 24, was a night to celebrate at ...

Researchers report that a three-year exercise program helped improve survival rates for people who have been treated for colon cancer. The findings could be helpful for doctors recommending ...

Exelixis' STELLAR-303 trial shows zanzalintinib plus Tecentriq improved survival in colorectal cancer, with no new safety ...

Colon cancer​ patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind international experiment.

A new study using one of the world's largest cancer registries shows that patient outcomes can be significantly impacted ...

Colorectal cancer (CRC) is the second most common cause of death from cancer in the United States (US) and the most prevalent ...

"A 3-year structured exercise program improves quality of life, reduces cancer recurrence and increases survival," Dr. Christopher Booth told Newsweek.

I became a colon cancer survivor after my 2020 diagnosis, and I share how my scars, mindset shifts and journaling helped me ...

Colon cancer patients who exercised regularly post-treatment had a 37% higher survival rate, emphasizing the importance of exercise in cancer recovery.